As of 2025-11-03, the Relative Valuation of Antibe Therapeutics Inc (ATE.TO) is (5.74) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.30 CAD, the upside of Antibe Therapeutics Inc based on Relative Valuation is -2047.3%.
The range of the Relative Valuation is (4.60) - (11.33) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 32.5x | 16.2x |
| Forward P/E multiples | 12.8x - 32.0x | 16.2x |
| Fair Price | (4.60) - (11.33) | (5.74) |
| Upside | -1657.8% - -3941.7% | -2047.3% |
| Date | P/E |